XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($)
$ in Thousands
Total
Registered Direct Offering
At The Market Program
Common Stock
Common Stock
Restricted stock units
Common Stock
Registered Direct Offering
Common Stock
At The Market Program
Additional paid-in capital
Additional paid-in capital
Registered Direct Offering
Additional paid-in capital
At The Market Program
Treasury stock
Accumulated other comprehensive loss
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2023       90,303,985                  
Beginning balance at Dec. 31, 2023 $ 51,675             $ 344,144     $ (8,603) $ (33) [1] $ (283,833)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (15,178)                       (15,178)
Other comprehensive loss (137)                     (137) [1]  
Exercise of stock options and RSUs vested (in shares)         227,622                
Payments for withholding taxes related to the net share settlement of equity awards (184)             (184)          
Stock-based compensation 1,446             1,446          
Ending balance (in shares) at Mar. 31, 2024       90,531,607                  
Ending balance at Mar. 31, 2024 37,622             345,406     (8,603) (170) [1] (299,011)
Beginning balance (in shares) at Dec. 31, 2023       90,303,985                  
Beginning balance at Dec. 31, 2023 51,675             344,144     (8,603) (33) [1] (283,833)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (33,279)                        
Ending balance (in shares) at Jun. 30, 2024       91,104,087                  
Ending balance at Jun. 30, 2024 19,064             345,160     (8,603) (381) [1] (317,112)
Beginning balance (in shares) at Mar. 31, 2024       90,531,607                  
Beginning balance at Mar. 31, 2024 37,622             345,406     (8,603) (170) [1] (299,011)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (18,101)                       (18,101)
Other comprehensive loss (211)                     (211) [1]  
Exercise of stock options and RSUs vested (in shares)       572,480                  
Exercise of stock options and RSUs vested 53             53          
Payments for withholding taxes related to the net share settlement of equity awards (111)             (111)          
Stock-based compensation (188)             (188)          
Ending balance (in shares) at Jun. 30, 2024       91,104,087                  
Ending balance at Jun. 30, 2024 19,064             345,160     (8,603) (381) [1] (317,112)
Beginning balance (in shares) at Dec. 31, 2024       96,015,320                  
Beginning balance at Dec. 31, 2024 (53,032)             356,247     (8,603) (571) [2] (400,105)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (32,581)                       (32,581)
Issuance of Common Stock under ATM Program (in shares)       275,587                  
Issuance of Common Stock under ATM Program 1,128             1,128          
Other comprehensive loss 257                     257 [2]  
Exercise of stock options and RSUs vested (in shares)       1,175,349                  
Exercise of stock options and RSUs vested 916             916          
Payments for withholding taxes related to the net share settlement of equity awards (375)             (375)          
Stock-based compensation 595             595          
Ending balance (in shares) at Mar. 31, 2025       97,466,256                  
Ending balance at Mar. 31, 2025 (83,092)             358,511     (8,603) (314) [2] (432,686)
Beginning balance (in shares) at Dec. 31, 2024       96,015,320                  
Beginning balance at Dec. 31, 2024 (53,032)             356,247     (8,603) (571) [2] (400,105)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (39,233)                        
Ending balance (in shares) at Jun. 30, 2025       105,244,548                  
Ending balance at Jun. 30, 2025 (68,113)             379,393     (8,603) 435 [2] (439,338)
Beginning balance (in shares) at Mar. 31, 2025       97,466,256                  
Beginning balance at Mar. 31, 2025 (83,092)             358,511     (8,603) (314) [2] (432,686)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (6,652)                       (6,652)
Issuance of Common Stock under ATM Program (in shares)           6,451,612 496,940            
Issuance of Common Stock under ATM Program   $ 18,769 $ 1,456           $ 18,769 $ 1,456      
Other comprehensive loss 749                     749 [2]  
Exercise of stock options and RSUs vested (in shares)       829,740                  
Exercise of stock options and RSUs vested 359             359          
Payments for withholding taxes related to the net share settlement of equity awards (278)             (278)          
Stock-based compensation 576             576          
Ending balance (in shares) at Jun. 30, 2025       105,244,548                  
Ending balance at Jun. 30, 2025 $ (68,113)             $ 379,393     $ (8,603) $ 435 [2] $ (439,338)
[1] Accumulated other Comprehensive loss consists of cumulative translation adjustments resulting from translating non-U.S. dollar denominated functional currency entities.
[2] Accumulated other Comprehensive loss consists of cumulative translation adjustments resulting from translating non-U.S. dollar denominated functional currency entities.